Adverum Biotechnologies (ADVM) Tops Q1 EPS by 2c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q1 EPS of ($0.29), $0.02 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral
• Deere shares climb as fiscal Q3 earnings and revenue top estimates